Science Explorer Interactive view Map
Company · Burlington · Canada

EVERSANA (Canada)

In research, EVERSANA (Canada) stands highest in Medicine (#8,688 of 10,443 worldwide) and Health Sciences (#10,051 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Economics and Econometrics and Economics, Econometrics and Finance — Economics and Econometrics is 11.4× its share of world research.

World rank, 2022–2025
#20,669
of 28,054 · #36,473 all time
Rank in Canada
#322
of 403
Research works
161
fractional, all time
Citations
859
5.3 per fractional work
Top-10% rate
10.8%
record average 16.5%
Open access
59%
world 28%

What is EVERSANA (Canada) known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
MedicineField #8,688 of 10,443 15.8%62
Health SciencesDomain #10,051 of 11,982 15.6%64

Each strip is that field’s whole ranked pool, with the notch where EVERSANA (Canada) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

What does EVERSANA (Canada) specialise in?

Where its research is concentrated relative to its size: Economics and Econometrics takes 11.4× the share of its output that it takes of world research.

  1. Economics and EconometricsSubfield · 21.2 works11×
  2. Economics, Econometrics and FinanceField · 21.3 works8.4×
← less than its size predictsmore →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.92× its world share, 6 worksBiochemistry, Geneti…Immunology and Microbiology: 3.89× its world share, 5 worksImmunology and Micro…Neuroscience: 0.05× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.23× its world share, 1 worksPharmacology, Toxico…Chemistry: 0.01× its world share, 0 worksChemistryComputer Science: 0.52× its world share, 5 worksComputer ScienceEnergy: 0.23× its world share, 0 worksEnergyEngineering: 0.29× its world share, 5 worksEngineeringEnvironmental Science: 0.09× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.04× its world share, 0 worksMaterials ScienceMathematics: 1.20× its world share, 2 worksMathematicsPhysics and Astronomy: 0.07× its world share, 0 worksPhysics and AstronomyDentistry: 0.12× its world share, 0 worksDentistryHealth Professions: 0.73× its world share, 2 worksHealth ProfessionsMedicine: 2.74× its world share, 62 worksMedicineNursing: 0.17× its world share, 0 worksNursingVeterinary: 0.52× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.21× its world share, 1 worksBusiness, Management…Decision Sciences: 3.56× its world share, 4 worksDecision SciencesEconomics, Econometrics and Finance: 8.45× its world share, 21 worksEconomics, Econometr…Psychology: 0.34× its world share, 1 worksPsychologySocial Sciences: 0.12× its world share, 2 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Economics, Econometrics and Finance, 8.4×. Every wedge is a field page.

Who are the top researchers at EVERSANA (Canada)?

Ranked on the composite score, Chris Cameron, Joanne Ellis and Nicole Ferko lead among researchers whose main affiliation is EVERSANA (Canada).

  1. 1 Chris Cameron Canada · #38,661 worldwide 987 citations · 31 works
  2. 2 Joanne Ellis Canada · #1,141,122 worldwide 0 citations · 24 works
  3. 3 Nicole Ferko Canada · #1,540,158 worldwide 8 citations · 19 works
All ranked researchers at EVERSANA (Canada)

Which keywords describe research at EVERSANA (Canada)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Quality of Life, Cost-effectiveness Analysis, Health Utility Measures, Epidemiology, Pharmaceutical Industry, Drug Development Costs, Generic Drugs and Prognostic Factors.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Quality of Life17▲ 9.9×12 topics
  2. Cost-effectiveness Analysis14▲ 141×1 topic
  3. Health Utility Measures14▲ 141×1 topic
  4. Epidemiology8▲ 1.82×35 topics
  5. Clinical Trials4▲ 5.3×10 topics
  6. Drug Development Costs4▲ 128×1 topic
  7. Generic Drugs4▲ 128×1 topic
  8. Pharmaceutical Industry4▲ 90×2 topics
  9. Prognostic Factors4▲ 7.4×8 topics
  10. Immunotherapy4▲ 4.5×10 topics
  11. Chemotherapy3▲ 3.8×12 topics
  12. Rituximab3▲ 18×3 topics
  13. Biomarkers3▲ 3.5×8 topics
  14. Clinical Outcomes3▲ 11×4 topics
  15. Autoantibodies3▲ 9.5×6 topics
  16. Precision Medicine3▲ 4.7×4 topics
  17. Genetic Mutations2▲ 4.9×6 topics
  18. Genomic Profiling2▲ 20×2 topics
  19. Biopharmaceuticals2▲ 40×3 topics
  20. Clinical Guidelines2▲ 7.1×6 topics
  21. Glaucoma2▲ 14×3 topics
  22. Glycemic Control2▲ 14×4 topics
  23. Monoclonal Antibodies2▲ 23×3 topics
  24. Primary Care2▲ 5.4×4 topics
  25. Clinical Practice Guidelines2▲ 3.6×6 topics
  26. Diabetes2▲ 4.0×4 topics
  27. Immunogenicity2▲ 44×3 topics
  28. Bioanalytical Methods2▲ 91×1 topic
  29. Biosimilars2▲ 91×1 topic
  30. Lymphoma2▲ 11×2 topics
  31. Prostate Cancer2▲ 14×3 topics
  32. Chronic Lymphocytic Leukemia2▲ 39×1 topic
  33. Forecasting2▲ 9.0×2 topics
  34. Genomic Aberrations2▲ 39×1 topic
  35. Minimal Residual Disease2▲ 24×2 topics
  36. Quality Assessment2▲ 9.0×2 topics
  37. Femtosecond Laser2▲ 32×1 topic
  38. Intraocular Lens Implantation2▲ 59×1 topic
  39. TGF-ß2▲ 9.9×3 topics
  40. Insulin Therapy2▲ 12×3 topics

Which research topics does EVERSANA (Canada) publish most on?

By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy, Biosimilars and Bioanalytical Methods and Chronic Lymphocytic Leukemia Research.

  1. 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 14 works
  2. 2 Pharmaceutical Economics and Policy Economics and Econometrics 4 works
  3. 3 Biosimilars and Bioanalytical Methods Immunology 2 works
  4. 4 Chronic Lymphocytic Leukemia Research Genetics 2 works
  5. 5 Intraocular Surgery and Lenses Ophthalmology 2 works
  6. 6 Multiple Myeloma Research and Treatments Hematology 2 works
  7. 7 Innovation Policy and R&D Economics and Econometrics 1 works
  8. 8 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 1 works
  9. 9 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 1 works
  10. 10 Clinical practice guidelines implementation Public Health, Environmental and Occupational Health 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available58.6%not open41.4%

World: 28% of research is openly available.

with international co-authors65.2%domestic only34.8%

World: 19% is written across borders.

How has EVERSANA (Canada)'s research output changed?

grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Burlington

All research institutions in Burlington

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.